Dose rate in the highest irradiation area of the rectum correlates with late rectal complications in patients treated with high-dose-rate computed tomography-based image-guided brachytherapy for cervical cancer.
brachytherapy
complications
intracavity radiotherapy
rectum
uterine cervical neoplasm
Journal
Journal of radiation research
ISSN: 1349-9157
Titre abrégé: J Radiat Res
Pays: England
ID NLM: 0376611
Informations de publication
Date de publication:
12 May 2021
12 May 2021
Historique:
received:
20
01
2021
revised:
21
02
2021
pubmed:
19
4
2021
medline:
26
11
2021
entrez:
18
4
2021
Statut:
ppublish
Résumé
The purpose of this study was to evaluate the effect of dose rate to the rectum on late rectal complications in patients treated with computed tomography (CT)-based image-guided brachytherapy (IGBT) for cervical cancer. The subjects were 142 patients with cervical cancer who underwent Ir-192 high-dose-rate (HDR)-IGBT between March 2012 and January 2018. The dose rate to the rectum was calculated using in-house software. The minimum, mean and maximum effective dose rate (EDR) was calculated for voxels of the rectal volume covered by cumulative doses >D0.1cc, >D2cc, and > D5cc. The average EDR of three to four brachytherapy sessions was calculated (EDR for patients; EDRp). The total dose of the rectum was calculated as the biologically equivalent dose in 2-Gy fractions (EQD2). The associations between EDRp for D0.1cc, D2cc, and D5cc and the respective rectal EQD2 values with late rectal complications were then analyzed. The median follow-up period was 40 months. Patients with rectal complications of ≥Grade 1 received a significantly higher mean EDRp for D0.1cc-5cc and had a greater EQD2 for D0.1cc-5cc. Multivariate analysis was performed using the mean EDRp for D2cc, EQD2 for D2cc, heavy smoking and BMI. Of these four variables, mean EDRp for D2cc (HR = 3.38, p = 0.004) and EQD2 for D2cc (HR = 2.59, p = 0.045) emerged as independent predictors for late rectal complications. In conclusion, mean EDRp and EQD2 were associated with late rectal complications in patients treated with HDR CT-based IGBT for cervical cancer.
Identifiants
pubmed: 33866361
pii: 6232580
doi: 10.1093/jrr/rrab023
pmc: PMC8127676
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
494-501Informations de copyright
© The Author(s) 2021. Published by Oxford University Press on behalf of The Japanese Radiation Research Society and Japanese Society for Radiation Oncology.
Références
Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):653-7
pubmed: 21345618
Int J Radiat Oncol Biol Phys. 1991 Nov;21(6):1403-14
pubmed: 1938548
Int J Radiat Oncol Biol Phys. 2001 Mar 1;49(3):839-45
pubmed: 11172968
Int J Radiat Oncol Biol Phys. 2012 Jul 1;83(3):e353-62
pubmed: 22483697
J Radiat Res. 2019 Mar 1;60(2):264-269
pubmed: 30649485
Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):250-5
pubmed: 21183288
Radiother Oncol. 2016 Sep;120(3):412-419
pubmed: 27396811
Int J Radiat Oncol Biol Phys. 2010 Jul 1;77(3):758-64
pubmed: 19836150
Int J Radiat Oncol Biol Phys. 1993 Feb 15;25(3):405-12
pubmed: 8436517
J Clin Oncol. 2002 Sep 1;20(17):3651-7
pubmed: 12202666
Gynecol Oncol. 2019 Mar;152(3):540-547
pubmed: 30665615
Phys Med Biol. 2017 Feb 01;62(4):1613-1631
pubmed: 28145285
Med Phys. 2004 Mar;31(3):633-74
pubmed: 15070264
J Radiat Res. 2010;51(2):173-9
pubmed: 20339254
Int J Radiat Oncol Biol Phys. 2002 Mar 1;52(3):850-7
pubmed: 11849811
Radiother Oncol. 2012 Jun;103(3):305-13
pubmed: 22633469
J Radiat Res. 2017 May 1;58(3):341-350
pubmed: 27837120
CA Cancer J Clin. 2019 Sep;69(5):386-401
pubmed: 31361333
Int J Radiat Oncol Biol Phys. 1994 Jul 30;29(5):953-60
pubmed: 8083096
Int J Radiat Oncol Biol Phys. 2011 Feb 1;79(2):356-62
pubmed: 20385450
Int J Radiat Oncol Biol Phys. 2007 Jun 1;68(2):491-8
pubmed: 17331668
Int J Radiat Oncol Biol Phys. 2013 Sep 1;87(1):111-9
pubmed: 23849695
Int J Radiat Oncol Biol Phys. 2008 Aug 1;71(5):1329-34
pubmed: 18439763